Changes in lipid measures and incident coronary heart disease: Tehran Lipid & Glucose Study

Clinical Biochemistry

Volumn 47, Issue 13-14, 2014, Pages 1239-1244

  Nejat, Amirahmad ^a   Mirbolouk, Mohammadhassan ^a   Mohebi, Reza ^a   Hasheminia, Mitra ^a   Tohidi, Maryam ^a   Saadat, Navid ^a   Azizi, Fereidoun ^b   Hadaegh, Farzad ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coronary heart disease; Dyslipidemia; Lipid change

Indexed keywords

CHOLESTEROL; GLUCOSE; HDL-TRIGLYCERIDE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

BLOOD; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HUMAN; IRAN; MALE; METABOLISM; MIDDLE AGED; RISK FACTOR;

CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; DYSLIPIDEMIAS; FEMALE; FOLLOW-UP STUDIES; GLUCOSE; HUMANS; IRAN; LIPIDS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; RISK FACTORS; TRIGLYCERIDES;

EID: 84929128970     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2014.03.004     Document Type: Article

References (34)

1. Murray C.J., Lopez A.D. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 1997, 349:1436-1442.
2. Hatmi Z.N., Tahvildari S., Gafarzadeh Motlag A., Sabouri Kashani A. Prevalence of coronary artery disease risk factors in iran: a population based survey. BMC Cardiovasc Disord 2007, 7:32.
3. Hadaegh F., Harati H., Ghanbarian A., Azizi F. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran lipid and glucose study. Eur J Cardiovasc Prev Rehabil 2006, 13:571-577.
4. Azizi F., Rahmani M., Ghanbarian A., Emami H., Salehi P., Mirmiran P., et al. Serum lipid levels in an iranian adults population: Tehran lipid and glucose study. Eur J Epidemiol 2003, 18:311-319.
5. Lewington S., Whitlock G., Clarke R., Sherliker P., Emberson J., Halsey J., et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007, 370:1829-1839.
6. Sarwar N., Danesh J., Eiriksdottir G., Sigurdsson G., Wareham N., Bingham S., et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 western prospective studies. Circulation 2007, 115:450-458.
7. Kannel W.B., McGee D., Gordon T. A general cardiovascular risk profile: the framingham study. Am J Cardiol 1976, 38:46-51.
8. Fornasini M., Brotons C., Sellares J., Martinez M., Galan M.L., Saenz I., et al. Consequences of using different methods to assess cardiovascular risk in primary care. Fam Pract 2006, 23:28-33.
9. Kreger B.E., Odell P.M., D'Agostino R.B., Wilson P.F. Long-term intraindividual cholesterol variability: natural course and adverse impact on morbidity and mortality-the Framingham study. Am Heart J 1994, 127:1607-1614.
10. Laitinen D.L., Manthena S. Impact of change in high-density lipoprotein cholesterol from baseline on risk for major cardiovascular events. Adv Ther 2010, 27:233-244.
11. Christen A., Efstathiadou Z., Laspa E., Johnston D.G., Godsland I.F. Rate of change and instability in body mass index, insulin resistance, and lipid metabolism as predictors of atherosclerotic vascular disease. J Clin Endocrinol Metab 2007, 92:3780-3787.
12. Koro C.E., Bowlin S.J., Stump T.E., Sprecher D.L., Tierney W.M. The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events. Am Heart J 2006, 151:755. (e1- e6).
13. Tirosh A., Rudich A., Shochat T., Tekes-Manova D., Israeli E., Henkin Y., et al. Changes in triglyceride levels and risk for coronary heart disease in young men. Ann Intern Med 2007, 147:377-385.
14. Azizi F., Ghanbarian A., Momenan A.A., Hadaegh F., Mirmiran P., Hedayati M., et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran lipid and glucose study phase ii. Trials 2009, 10:5.
15. Harati H., Hadaegh F., Momenan A.A., Ghanei L., Bozorgmanesh M.R., Ghanbarian A., et al. Reduction in incidence of type 2 diabetes by lifestyle intervention in a middle eastern community. Am J Prev Med 2010, 38:628-36 e1.
16. Azizi F., Rahmani M., Emami H., Mirmiran P., Hajipour R., Madjid M., et al. Cardiovascular risk factors in an iranian urban population: Tehran lipid and glucose study (phase 1). Soz Praventivmed 2002, 47:408-426.
17. Chen Y., Zhang X., Pan B., Jin X., Yao H., Chen B., et al. A modified formula for calculating low-density lipoprotein cholesterol values. Lipids Health Dis 2010, 9:52.
18. Third report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii) final report. Circulation 2002, 106:3143-3421.
19. Luepker R.V., Apple F.S., Christenson R.H., Crow R.S., Fortmann S.P., Goff D., et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; The European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and The National Heart, Lung, and Blood Institute. Circulation 2003, 108:2543-2549.
20. Patel A., Barzi F., Jamrozik K., Lam T.H., Ueshima H., Whitlock G., et al. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation 2004, 110:2678-2686.
21. Geurian K., Pinson J.B., Weart C.W. The triglyceride connection in atherosclerosis. Ann Pharmacother 1992, 26:1109-1117.
22. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
23. Tremblay A.J., Morrissette H., Gagne J.M., Bergeron J., Gagne C., Couture P. Validation of the friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clin Biochem 2004, 37:785-790.
24. Hadaegh F., Bozorgmanesh M.R., Ghasemi A., Harati H., Saadat N., Azizi F. High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the iranian urban population: Tehran lipid and glucose study. BMC Public Health 2008, 8:176.
25. Zabetian A., Hadaegh F., Azizi F. Prevalence of metabolic syndrome in iranian adult population, concordance between the idf with the atpiii and the who definitions. Diabetes Res Clin Pract 2007, 77:251-257.
26. Hadaegh F., Khalili D., Ghasemi A., Tohidi M., Sheikholeslami F., Azizi F. Triglyceride/hdl-cholesterol ratio is an independent predictor for coronary heart disease in a population of iranian men. Nutr Metab Cardiovasc Dis 2009, 19:401-408.
27. Brenner H., Heiss G. The intraindividual variability of fasting triglyceride-a challenge for further standardization. Eur Heart J 1990, 11:1054-1058.
28. Jacobs D.R., Barrett-Connor E. Retest reliability of plasma cholesterol and triglyceride. The lipid research clinics prevalence study. Am J Epidemiol 1982, 116:878-885.
29. Abate N., Vega G.L., Grundy S.M. Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein b-100. Atherosclerosis 1993, 104:159-171.
30. Thygesen K., Alpert J.S., Jaffe A.S., Simoons M.L., Chaitman B.R., White H.D., et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012, 60:1581-1598.
31. Coloma P.M., Valkhoff V.E., Mazzaglia G., Nielsson M.S., Pedersen L., Molokhia M., et al. Identification of acute myocardial infarction from electronic healthcare records using different disease coding systems: a validation study in three european countries. BMJ Open 2013, 3.
32. Dalgard C., Christiansen L., Vogel U., Dethlefsen C., Tjonneland A., Overvad K. Variation in the sodium-dependent vitamin c transporter 2 gene is associated with risk of acute coronary syndrome among women. PLoS ONE 2013, 8:e70421.
33. Pai J.K., Cahill L.E., Hu F.B., Rexrode K.M., Manson J.E., Rimm E.B. Hemoglobin a1c is associated with increased risk of incident coronary heart disease among apparently healthy, nondiabetic men and women. J Am Heart Assoc 2013, 2:e000077.
34. Safford M.M., Brown T.M., Muntner P.M., Durant R.W., Glasser S., Halanych J.H., et al. Association of race and sex with risk of incident acute coronary heart disease events. JAMA 2012, 308:1768-1774.